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Abstract
Background: To evaluate prolapse-related symptoms, quality of life and sexuality of patients with validated
questionnaires before and after surgery for genital prolapse and assess relevance of such an evaluation to select
women for surgery.
Methods: From November 2009 to April 2010, 16 patients operated on for genital prolapse of grade greater than
or equal to 2 (POP-Q classification) were evaluated prospectively by three questionnaires of quality of life Pelvic
Floor Distress Inventory (PFDI-20), Pelvic Floor Impact Questionnaire (PFIQ-7) and Pelvic Organ Prolaps/Urinary
Incontinence Sexual Questionnaire (PISQ-12). Data were collected the day before surgery and 6 weeks
postoperatively.
Results: Eleven patients had laparoscopic surgery and five vaginal surgery. There was a significant decrease in
pelvic heaviness, vaginal discomfort and urinary symptoms after surgery. The score of symptoms of prolapse, the
PFDI-20 score was 98.5 preoperatively and 31.8 postoperatively (p < 0.0001). The score for quality of life, the PFIQ-7
score was 54.5 preoperatively and 7.4 postoperatively (p = 0.001). The score of sexuality, the PISQ-12 score was 35.3
preoperatively and 37.5 postoperatively (p = 0.1). Two of the 3 patients with a PFIQ 7 under or equal to 20 were
not improved while all the women with a preoperative PFIQ-7 over 20 were improved after surgery.
Conclusions: This study suggests that surgery improves quality of life of patients with genital prolapse. Quality of
life questionnaires could help select good candidates for surgery. Further studies are required to determine
threshold to standardize indications of surgery.
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Background
Genital prolapse, also known as pelvic organ prolapse
(POP), is a major public health issue in western popula-
tions where as many as 38% to 76% of women consult-
ing for routine gynaecological care suffer from the
condition [1]. The lifetime risk of these women under-
going genital prolapse surgery is estimated at 11.8% [2].
Patients referred for surgery frequently complain about
bulging and associated urinary, bowel or sexual symp-
toms, which are responsible for a significant decrease in
health-related quality of life [3-8].
The decision criteria for surgery are mainly based on
anatomical abnormalities [3,5]. However, there is no
objective argument to correlate anatomical abnormal-
ities with the impact on quality of life of patients with
genital prolapse. In other disorders, it has been shown
that the evaluation of symptoms or discomfort by analo-
gue scales did not correlate with changes in quality of
life after surgery [9]. Several quality of life question-
naires have been validated to evaluate changes after sur-
gery for genital prolapse, but none of them have been
used to clarify indications for surgery [10-17]. Hence, it
would be useful to have predictors of changes in quality
of life after treatment of genital prolapse to identify
good candidates for this functional surgery.* Correspondence: emile.darai@tnn.aphp.fr
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The objectives of this pilot study were to evaluate the
impact of surgery on quality of life in women with geni-
tal prolapse using validated quality of life questionnaires
and to assess whether these questionnaires could be
useful tools to select patients for surgery.
Methods
We conducted a pilot study from November 2009 to
April 2010 on prospective data of patients undergoing
genital prolapse repair. Women either underwent
laparoscopic sacrocolpopexy (LSC) or surgery by vaginal
route using synthetic or biological mesh. The latter
approach was recommended in patients with co-morbid-
ities contraindicating the laparoscopic approach such as
severe respiratory failure, morbid obesity or prior multi-
ple surgery by laparotomy. Among the 16 patients
included in this pilot study, 11 underwent an LSC and
five a vaginal route. The decision to include sling in the
procedure was done according to clinical and urody-
namic stress incontinence.
Preoperative and follow-up pelvic examinations to
evaluate genital prolapse stage used the International
Continence Society pelvic organ prolapse quantification
system (POPQ) [18]. The maximal extent of prolapse
was clinically measured during a Valsalva maneuver or
coughing and was confirmed by the patient as being the
most severe protrusion. Anatomical recurrence was
defined POPQ stage ≥ II (≥ -1 cm). All patients gave
written informed consent to participate in this pilot
study. Ethical Committee approved this pilot study.
Surgical techniques
For LSC, lightweight macroporous polypropylene mesh
(Parietex® Covidien, USA) was used. All patients were
operated on under general anaesthesia. After CO2 intra-
peritoneal insufflation at 12 mmHg with a Veress nee-
dle, a 12 mm trocar was inserted at the umbilicus for
the scope, two 5 mm trocars at the right and left iliac
fossae, and a suprapubic incision made for a 15 mm tro-
car. The first step of the procedure consisted of a subto-
tal hysterectomy with bilateral oophorectomy for
postmenopausal patients if the uterus was still in place.
Vesicovaginal cleavage was extended to the lower third
of the vagina. The uterus and adnexes were extracted
using an electric morcellator. The second step of the
procedure began by continuing the rectovaginal dissec-
tion to the lower third of the posterior vaginal wall and
then extending it laterally to visualize the levator ani
muscle fascia. Next, the peritoneum facing the sacral
promontory was opened to visualize the anterior verteb-
ral ligament. The peritoneal opening was extended
downwards so as to join the rectovaginal dissection. The
posterior mesh was secured to the levator ani muscle
fascia using nonabsorbable sutures or staples. The
anterior mesh was then secured to the anterior vaginal
wall using three nonabsorbable sutures. Finally, the
anterior and posterior meshes were secured to the ante-
rior vertebral ligament at the sacral promontory using a
nonabsorbable suture or staples before closing the peri-
toneum with absorbable sutures. After exsufflation, the
skin incisions were closed with absorbable sutures as
well. A Foley catheter was left in place for 24 hours.
For the vaginal route a mixed mesh composed of poly-
propylene and porcine dermis was used (Avaulta®
implant from Baxter, USA). Surgery was performed with
the patient in the dorsal lithotomy position under gen-
eral or spinal anaesthesia. Genital prolapse repair was
preceded by vaginal hysterectomy. If the latter had
already been performed, an incision was made at the
vaginal apex. The vaginal mucosa was separated from
the bladder by dissection. After incising the perineal
skin facing the obturator membrane, the endopelvic fas-
cia was perforated with Avaulta kit from the skin to the
incised vaginal wall according to laboratory recommen-
dations [19]. The same procedure was performed on the
contralateral side. Then approximation of the mesh
under the urethra and bladder was performed. Finally,
the colpotomy and skin incisions were closed with
absorbable sutures. A Foley catheter was left in place for
24 hours.
Follow-up pelvic examination was carried out 4 to 6
weeks after surgery, then once every six months up to
date. Patients were asked to answer validated quality of
life questionnaires at the preoperative visit and then at
each follow-up visit or through telephone interviews by
investigators who were blinded to the type of surgery.
The short version of the Pelvic Floor Distress Inventory
(PFDI-20), the Pelvic Floor Impact Questionnaire
(PFIQ-7) and Pelvic Organ Prolaps/Urinary Inconti-
nence Sexual Questionnaire (PISQ-12) were used
[13-15].
The PFDI-20 assesses the presence and amount of dis-
tress caused by 20 symptoms related to pelvic floor dis-
orders. It is composed of three sub-questionnaires; the
Pelvic Organ Prolapse Distress Inventory (POPDI-6)
which includes 6 items, the Colon Rectal Anal Distress
Inventory (CRADI-8) which includes 8 items and the
Urinary Distress Inventory (UDI-6) which includes 6
items. Patients were asked if they experienced each
symptom, and if so, how much the symptom bothered
them on a scale of 1 (not at all) to 4 (severe). Scores for
each sub-questionnaire range from 0 to 100 with higher
scores indicating greater symptom distress.
The PFIQ-7 assesses the impact of symptoms on
activities of daily living. It is composed of three sub-
questionnaires consisting of 7 items each; the Pelvic
Organ Prolapse Impact Questionnaire (POPIQ-7), the
Colon Rectal Anal Impact Questionnaire (CRAIQ-7)
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and the Urinary Impact Questionnaire (UIQ-7). Scores
for each sub-questionnaire range from 0 to 100 with
higher scores indicating greater symptom distress.
The PISQ-12 assesses the impact of symptoms on sex-
ual satisfaction and includes 12 items scored from 0 to
4. Total scores range from 0 to 48 with higher scores
indicating greater sexual satisfaction.
Statistical analysis
Statistical analyses were carried out using the R 2.11®
software. Qualitative variables were compared using the
Fisher’s exact test or Chi2 test, and quantitative vari-
ables by the Wilcoxon rank-sum test. A p value of 0.05
denoted a significant difference.
Results
Epidemiological and surgical characteristics of the
patients
The mean age of the patients was 63 years (range: 42-
88) and the mean body mass index (BMI) was 25.5 kg/
m2 (range: 17.9-32.7). The mean parity was 3 (range: 2-
6). A history of surgery for urinary incontinence was
noted in one patient and a previous operation for genital
prolapse in another. Eleven of the 16 patients were
menopausal including one patient on hormone replace-
ment therapy.
Twelve of the 16 patients underwent a hysterectomy
including seven with bilateral salpingo-oophorectomy.
Among the four remaining patients, three had conserva-
tive surgery and one had underwent previously hyster-
ectomy for fibroma. Three patients had stress urinary
incontinence treated by a suburethral sling procedure
via the transobturator route. One of the five patients
undergoing vaginal route underwent a bilateral sacrospi-
nous fixation. None of the patients had a posterior
colpoperineorrhaphy.
The mean drop in hemoglobin was 1.5 g/dl (range:
0.1-3.5). No patient required a blood transfusion. No
bowel, bladder or ureteral injury was observed. The
mean hospital stay was 2.3 days (range: 2-5).
Changes in symptoms and anatomical results after
surgical treatment for genital prolapse
A significant decrease in pelvic pain was observed (13
patients preoperatively vs one postoperatively) (p < 0.01)
and in vaginal discomfort (15 patients preoperatively vs
none postoperatively) (p < 0.01). No patient reported de
novo pelvic pain or vaginal discomfort. No difference in
urinary dysfunction was observed: two patients experi-
enced pollakiuria preoperatively vs none postoperatively;
four patients experienced nocturia preoperatively vs
none postoperatively; and three patients experienced
urgency preoperatively vs two postoperatively. No
patients reported de novo urinary symptoms, anorectal
symptoms or pre-or postoperative constipation. One
patient reported pain on defecation preoperatively as
opposed to none postoperatively.
At the first postoperative visit, 15 patients had optimal
anatomic results and one operated on via the vaginal
route had persistent asymptomatic posterior prolapse
(-2 cm).
The median follow-up was 16 months (range: 14-19).
No recurrence of genital prolapse and no mesh infection
or rejection was observed during follow-up whatever the
surgical route.
Changes in quality of life
Changes in quality of life assessed by PFDI-20, PFIQ-7
and PISQ-20 questionnaires Pelvic Floor Distress Inven-
tory (PFDI-20), Pelvic Floor Impact Questionnaire
(PFIQ-7) and Pelvic Organ Prolaps/Urinary Inconti-
nence Sexual Questionnaire (PISQ-12) are summarized
in Table 1.
The PFDI-20 questionnaire revealed a decrease in
symptoms related to prolapse (p < 0.0001). This
decrease was significant for the three sub-question-
naires, the POPDI-6 (Pelvic Organ Prolapse Distress
Inventory) (p < 0.0004), the CRADI-8 (Colon Rectal
Anal Distress Inventory) (p = 0.01) and UDI-6 (Urinary
Distress Inventory) (p = 0.001). Analysis of the PFDI-20
scores per patient showed that all the 16 patients were
improved by surgery.
An overall significant improvement in quality of life
was shown by the PFIQ-7 scores (p = 0.001): the
POPIQ-7 (Pelvic Organ Prolapse Impact Questionnaire)
(p = 0.009), the CRAIQ-7 (Colon Rectal Anal Impact
Questionnaire) (p = 0.03) and the UIQ-7 (Urinary
Impact Questionnaire) (P = 0.003). Analysis of the
PFIQ-7 scores per patient showed that the 13 patients
with a preoperative PFIQ-7 above 20 were improved by
surgery while two of the three patients with a preopera-
tive PFIQ-7 under or equal to 20 reported no improve-
ment after surgery. These patients were elderly patients
with mean age of 78 years with predominant anterior
prolapse and two of them were operated on via the vagi-
nal route.
The PISQ-12 scores did not show improvement in
sexual quality of life after surgery (p = 0.1).
Discussion
The present pilot study demonstrates that quality of life
of patients with advanced stage of genital prolapse was
improved by surgery and indicates that the PFIQ-7 is
the most appropriate questionnaire to identify patients
that could benefit from surgery.
The aim of genital prolapse surgery is not only anato-
mical correction but also to improve functional symp-
toms and quality of life. A recent Cochrane review of
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the surgical management of genital prolapse noted that
the impact of surgery on associated pelvic floor symp-
toms and quality of life were poorly reported explaining
why it is difficult to identify good candidates for this
functional surgery [20]. After failure of perineal rehabili-
tation and the use of pessaries, current recommenda-
tions suggest that surgery should be an option for
women with advanced stages of genital prolapse. But the
use of exclusive anatomical criteria seems questionable
as no strict relation exists between anatomical correc-
tion and improvement in symptoms and quality of life
[21,22]. Visual analogue scales assessing the intensity of
symptoms associated with genital prolapse could be
used but to date there are no guidelines as to the
threshold at which surgery is recommended. Moreover,
particularly for patients with endometriosis, a low corre-
lation between evaluation of symptoms by visual analo-
gue scale and changes in quality of life after surgery has
been shown [23]. On the other hand, the usefulness of
quality of life questionnaires for selecting patients who
could derive benefit from surgery has already been
demonstrated [23]. Recently, several reports have
demonstrated the very good psychometric properties of
quality of life questionnaires to evaluate the impact of
genital prolapse with a Cronbach’s alpha greater than
0.70 for all items, confirming that questionnaires are
able to detect changes in quality-of-life after treatment
[24,25]. However, to our knowledge, no study has
attempted to assess the contribution of quality of life
questionnaires specific to genital prolapse to identify
good candidates for surgery.
Analysis of the pre- and postoperative values of the
PFDI-20 showed that all 16 patients of this pilot study
experienced an improvement in quality of life. These
results are consistent with those of previous reports
showing the positive impact of genital prolapse surgery
[26]. In a review of the literature on laparoscopic treat-
ment of genital prolapse, Ganatra et al. reported a
patient satisfaction of 94.4% with a median follow-up of
24.6 months [26]. In addition, our data are consistent
with those of retrospective studies demonstrating a sig-
nificant improvement in quality of life after surgical
cure of genital prolapse by both vaginal route and
laparoscopy [22,26-31]. Moreover, unlike retrospective
series, our study shows an improvement in anorectal
symptoms assessed by the sub-questionnaire CRADI-8
[32]. Similar results were noted using the PFIQ-7 ques-
tionnaire. In this pilot study, even if all the patients had
advanced genital prolapse stages, a wide spectrum of
quality of life questionnaire scores was observed. Scores
from the PFDI-20 questionnaire ranged from 33 to 235
(on a scale of 0 to 300). Similarly, the preoperative
PFIQ-7 questionnaire scores ranged from 0 to 162. It is
important to note that some patients did not report
impairment in quality of life related to genital prolapse.
The apparent low impact of genital prolapse on sexual
quality of life observed in this study suggests that the
PISQ-12 questionnaire is not a useful tool to select can-
didates for genital prolapse surgery. This is in agreement
with previous studies showing no improvement or dete-
rioration in the sexual quality of life after genital pro-
lapse cure [21,22]. Moreover, the PISQ-12 questionnaire
can only be used for sexually active patients.
However, even if postoperative improvement in quality
of life has been demonstrated in series of patients, it
remains difficult to predict impact on an individual
basis. To date, no nomogram or recursive partitioning
model to select patients for surgery has been developed.
Our results are too preliminary to determine which
questionnaire could be used to construct a nomogram
predicting good outcome after surgery. However, the
PFDI-20 questionnaire has the advantage of giving a
wide distribution of preoperative values but with a ratio
of pre-over postoperative mean values of 3 (98.5 preo-
peratively vs 31.8 postoperatively). The PFIQ-7 ques-
tionnaire gives preoperative values that are relatively
scattered but the pre-over postoperative mean value
ratio was 7 (54.5 vs 7.4) suggesting a higher power of
Table 1 Quality of life evaluated by the PFDI-20, PFIQ-7 and PISQ-12 questionnaires before and after surgery for
genital prolapsed
Preoperative values Median (range) Postoperative values Median (range) P value
PFDI-20 98.5 (33-235) 31.8 (0-103) < 0.0001
POPDI-6 46.1 (8-100) 10.1 (0-33) 0.0004
CRADI-8 23.5 (0-79) 12.5 (0-53) 0.01
UDI-6 30.4 (0-91) 9.1 (0-33) 0.001
PFIQ-7 54.5 (0-162) 7.4 (0-43) 0.001
UIQ-7 25.3 (0-76) 3 (0-19) 0.009
CRAIQ-7 11.6 (0-52) 3.6 (0-43) 0.03
POPIQ-7 17.6 (0-52) 0.9 (0-14) 0.003
PISQ-12 35.3 (27-41) 37.5 (30-46) 0.1
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discrimination compared to the PFDI-20. Moreover, the
PFIQ-7 can identify patients who are not likely to bene-
fit from surgery. Indeed, two of the three patients with a
preoperative PFIQ-7 less than or equal to 20 had no
improvement in quality of life after surgery while the
remaining 13 patients with a preoperative PFIQ-7 above
20 were improved. Our results are in accordance with
those of Lawndy et al. [33] showing that even if no dif-
ference was observed in anatomical results, some
patients reported the absence of symptoms
improvement.
This pilot study therefore gives some important poin-
ters to calculate sample size for a study to build a pre-
dictive model of quality of life improvement after genital
prolapse cure. Taking into account that two of the 16
patients had no improvement using the PFIQ-7 ques-
tionnaire and that at least 50 patients with no improve-
ment are required to built a predictive model, at least
400 patients would be required for such a study.
The limitations of this pilot study should be high-
lighted. First, the low number of patients may be a
potential source of bias. Despite this disadvantage, our
pilot study underlined the wide spectrum of preopera-
tive values to quality of life questionnaires in patients
with genital prolapse. Even if all our patients had
advanced genital prolapse stage, they represented a het-
erogeneous population underlining that anatomical
abnormalities associated with genital prolapse are insuf-
ficient to select patients for surgery. Second, two routes
for genital prolapse cure were used. It is possible that
the type of surgery could influence changes in quality of
life. Finally, the short follow-up cannot exclude the risk
of overestimating the benefit of surgery.
Conclusions
Despite the limits of this pilot study, our data indicate
that quality of life questionnaires could be a useful tool
to select patients for genital prolapse surgery. Further
large studies are obviously required taking into account
quality of life not only of patients with advanced genital
prolapse stages but also the route of surgical manage-
ment, to determine a threshold to standardize indica-
tions for surgery.
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